Literature DB >> 12119288

Stimulation of enveloped virus infection by beta-amyloid fibrils.

Woj M Wojtowicz1, Michael Farzan, John L Joyal, Kara Carter, Gregory J Babcock, David I Israel, Joseph Sodroski, Tajib Mirzabekov.   

Abstract

Alzheimer's disease is characterized by deposition of beta-amyloid peptide (Abeta) into plaques in the brain, leading to neuronal toxicity and dementia. Human immunodeficiency virus type 1 (HIV-1) infection of the central nervous system can also cause a dementia, and amyloid deposition in the central nervous system is significantly higher in HIV-1-infected individuals compared with uninfected controls. Here we report that Abeta fibrils stimulated, by 5-20-fold, infection of target cells expressing CD4 and an appropriate coreceptor by multiple HIV-1 isolates but did not permit infection of cells lacking these receptors. Abeta enhanced infection at the stage of virus attachment or entry into the cell. Abeta fibrils also stimulated infection by amphotrophic Moloney leukemia virus, herpes simplex virus, and viruses pseudotyped with the envelope glycoprotein of vesicular stomatitis virus. Other synthetic fibril-forming peptides similarly enhanced viral infection and may be useful in gene delivery applications utilizing retroviral vectors. These data suggest that Abeta deposition may increase the vulnerability of the central nervous system to enveloped viral infection and that amyloidogenic peptides could be useful in enhancing gene transfer by enveloped viral vectors.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12119288     DOI: 10.1074/jbc.M203518200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  32 in total

Review 1.  Herpes simplex virus type 1 persists in the aged brain through hypothetical expression of accessory genes.

Authors:  Isamu Mori
Journal:  J Neurovirol       Date:  2010-05       Impact factor: 2.643

2.  PCR search for the herpes simplex virus type 1 genome in brain sections of patients with familial Alzheimer's disease.

Authors:  Isamu Mori; Takashi Yokochi; Naoki Koide; Tsuyoshi Sugiyama; Tomoaki Yoshida; Yoshinobu Kimura; Hironobu Naiki; Rokuro Matsubara; Tohru Takeuchi; Yukihiro Nishiyama
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

Review 3.  From Alzheimer to Huntington: why is a structural understanding so difficult?

Authors:  Piero Andrea Temussi; Laura Masino; Annalisa Pastore
Journal:  EMBO J       Date:  2003-02-03       Impact factor: 11.598

4.  Antiviral agents in Alzheimer's disease: hope for the future?

Authors:  Matthew A Wozniak; Ruth F Itzhaki
Journal:  Ther Adv Neurol Disord       Date:  2010-05       Impact factor: 6.570

Review 5.  Mechanisms of the blood-brain barrier disruption in HIV-1 infection.

Authors:  Michal Toborek; Yong Woo Lee; Govinder Flora; Hong Pu; Ibolya E András; Edward Wylegala; Bernhard Hennig; Avindra Nath
Journal:  Cell Mol Neurobiol       Date:  2005-02       Impact factor: 5.046

Review 6.  Versatile somatic gene transfer for modeling neurodegenerative diseases.

Authors:  Ronald L Klein; David B Wang; Michael A King
Journal:  Neurotox Res       Date:  2009-08-11       Impact factor: 3.911

7.  PB1-F2 influenza A virus protein adopts a beta-sheet conformation and forms amyloid fibers in membrane environments.

Authors:  Christophe Chevalier; Ali Al Bazzal; Jasmina Vidic; Vincent Février; Christiane Bourdieu; Edwige Bouguyon; Ronan Le Goffic; Jean-François Vautherot; Julie Bernard; Mohammed Moudjou; Sylvie Noinville; Jean-François Chich; Bruno Da Costa; Human Rezaei; Bernard Delmas
Journal:  J Biol Chem       Date:  2010-02-19       Impact factor: 5.157

8.  The amyloidogenic SEVI precursor, PAP248-286, is highly unfolded in solution despite an underlying helical tendency.

Authors:  Jeffrey R Brender; Ravi Prakash Reddy Nanga; Nataliya Popovych; Ronald Soong; Peter M Macdonald; Ayyalusamy Ramamoorthy
Journal:  Biochim Biophys Acta       Date:  2011-01-22

9.  Helical conformation of the SEVI precursor peptide PAP248-286, a dramatic enhancer of HIV infectivity, promotes lipid aggregation and fusion.

Authors:  Jeffrey R Brender; Kevin Hartman; Lindsey M Gottler; Marchello E Cavitt; Daniel W Youngstrom; Ayyalusamy Ramamoorthy
Journal:  Biophys J       Date:  2009-11-04       Impact factor: 4.033

10.  Activation of virus uptake through induction of macropinocytosis with a novel polymerizing peptide.

Authors:  Sarah I Daniels; Erin E Soule; Katharine S Davidoff; John G Bernbaum; Duosha Hu; Kenji Maeda; Stephen J Stahl; Nicole E Naiman; Abdul A Waheed; Eric O Freed; Paul Wingfield; Robert Yarchoan; David A Davis
Journal:  FASEB J       Date:  2013-10-04       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.